Evidence map›Paper›PMID 41302446›Full record

ArticleMolecules (Basel, Switzerland)2025

Synthesis of 1

Killian Malosse, Béatrice Josselin, Sandrine Ruchaud, Fabrice Anizon, Francis Giraud, Pascale Moreau

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Killian MalosseICCF, Clermont Auvergne INP, CNRS, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.ORCID 0009-0008-8141-4374
Béatrice JosselinStation Biologique, Protein Phosphorylation and Human Diseases Unit, Plateforme de Criblage KISSf (Kinase Inhibitor Specialized Screening Facility), CNRS, Sorbonne Université, Place Georges Teissier, F-29688 Roscoff, France.
Sandrine RuchaudStation Biologique, CNRS UMR8227, Sorbonne Université, Place Georges Teissier, CS90074, F-29688 Roscoff cedex, France.
Fabrice AnizonICCF, Clermont Auvergne INP, CNRS, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Francis GiraudICCF, Clermont Auvergne INP, CNRS, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.ORCID 0000-0001-7600-3687
Pascale MoreauICCF, Clermont Auvergne INP, CNRS, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.ORCID 0000-0001-6527-7586

Funding

Biogenouest Not applicableITMO Cancer AVIESAN Not applicableLa Ligue Contre le Cancer not applicableUniversité Clermont Auvergne Not applicable
6 · The paper itself

Abstract

A new series of 1

Indexed as

Intracellular Signaling Peptides and ProteinsIsoquinolinesProtein Kinase InhibitorsProtein Serine-Threonine KinasesPyrrolesHumansLigandsMolecular StructureStructure-Activity RelationshipIntracellular Signaling Peptides and ProteinsIsoquinolinesLigandsProtein Kinase InhibitorsProtein Serine-Threonine KinasesPyrrolesHaspinkinase inhibitionpyrroloisoquinolines

Identifiers

PMID41302446
PMCPMC12655252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.